Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Glucagon-Like Peptide 2 Receptor (GLP2R) Peptide

GLP2R Reactivity: Mammalian Host: Synthetic BP, WB, IHC
Catalog No. ABIN939896
  • Target See all GLP2R products
    GLP2R (Glucagon-Like Peptide 2 Receptor (GLP2R))
    Peptide Type
    Synthetic
    Origin
    Mammalian
    Source
    • 3
    Synthetic
    Application
    Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
    Sequence
    KLGSSRAGPG RGSAGLLPGV HELPMGIPAP WGTSPLSFHR KCSLWAPGRP
    Characteristics
    A synthetic peptide for use as a blocking control in assays to test for specificity of GLP2 R antibody,
    Alternative Names: GLP2R control peptide, GLP2R antibody Blocking Peptide, Anti-GLP2R Blocking Peptide, Glucagon-Like Peptide 2 Receptor Blocking Peptide, GLP-2R Blocking Peptide, GLP2, GLP-2, GLP 2, GLP-2 Blocking Peptide, GLP 2 Blocking Peptide
  • Application Notes
    Optimal conditions should be determined by the investigator
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
    Buffer
    PBS
    Handling Advice
    Avoid repeated freeze/thaw cycles.
    Storage
    -20 °C
    Storage Comment
    Store at -20 °C long term.
  • Target
    GLP2R (Glucagon-Like Peptide 2 Receptor (GLP2R))
    Synonyms
    9530092J08Rik Peptide, GLP-2 Peptide, glucagon like peptide 2 receptor Peptide, glucagon-like peptide 2 receptor Peptide, GLP2R Peptide, Glp2r Peptide
    Background
    The GLP2 receptor (GLP2R) is a G protein-coupled receptor superfamily member closely related to the glucagon receptor ans GLP1 receptor. Glucagon-like peptide-2 (GLP2) is a 33-amino acid proglucagon-derived peptide produced by intestinal enteroendocrine cells. Like glucagon-like peptide-1 (GLP1) and glucagon itself, it is derived from the proglucagon peptide encoded by the GCG gene. GLP2 stimulates intestinal growth and upregulates villus height in the small intestine, concomitant with increased crypt cell proliferation and decreased enterocyte apoptosis. Moreover, GLP2 prevents intestinal hypoplasia resulting from total parenteral nutrition.
    Molecular Weight
    61 kDa
You are here:
Support